Home
Conditions
Recurrent Ovarian Carcinoma

Clinical trial condition

Recurrent Ovarian Carcinoma

Explore clinical trials studying Recurrent Ovarian Carcinoma. Study availability and eligibility vary by location and protocol.

111 public trials 14 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Ovarian Carcinoma trial results

Recruiting

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

NCT03968406

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +46 more
Locations: Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study

NCT06855706

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +30 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Recruiting

Secondary Interval Cytoreductive Surgery in Platinum-sensitive Recurrent Epithelial Ovarian Cancer

NCT06292286

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: The University of Hong Kong Hong Kong

View Trial Details

Recruiting

Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics

NCT04315233

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasms, +18 more
Locations: Huntsman Cancer Institute Salt Lake City, Utah, United States

Inova Schar Cancer Institute Fairfax, Virginia, United States

View Trial Details

Not Yet Recruiting

A New Fast DWI-based MR Protocol for Surveillance in Patients With a High Risk of Ovarian Cancer Recurrence During PARP-inhibitors Maintenance to Enhance Secondary Cytoreduction Results

NCT06541171

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations: Fondazione Policlinico Universitaro "A. Gemelli" IRCCS Roma, Italy

View Trial Details

Completed

Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT03586661

Conditions: Adnexal Diseases, Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, +32 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Pembrolizumab and Carboplatin for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT04387227

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

NCT02111941

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +37 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Primary Ovarian or Uterine Cancer

NCT03325634

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
Locations: University of Colorado Hospital Aurora, Colorado, United States

View Trial Details

Completed

Durvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT03026062

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +23 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recurrent Ovarian Carcinoma

Recurrent Ovarian Carcinoma trial results

Related conditions